Joint stakeholder statement on access to innovative healthcare under the Artificial Intelligence Act (AI Act)
Date
Sections
MedTech Europe is writing to you on behalf of 11 healthcare stakeholders representing patients, healthcare professionals and the medical technology industry, to share our joint statement on access to innovative healthcare under the AI Act. We hereby provide our joint views on how the AI Act can give citizens the confidence to embrace AI-based solutions, including AI-enabled digital health services and tools.
In the statement, we offer four considerations to be taken into account during the trilogue negotiations. The AI Act must:
- align with all relevant horizontal and sectoral European laws and concepts;
- provide more clarity on the definitions;
- provide a clear data and data governance framework as data is indispensable for AI;
- ensure uniform application and implementation of its provisions across Member States regarding its governance structure to avoid unnecessary fragmentation within the Single Market.
Should you have any further questions, please do not hesitate to contact MedTech Europe.
About MedTech Europe
MedTech Europe is the European trade association for the medical technology industry including diagnostics, medical devices and digital health. Our members are national, European and multinational companies as well as a network of national medical technology associations who research, develop, manufacture, distribute and supply health-related technologies, services and solutions.
For press enquiries, please contact:
Jessica Imbert
Director External Affairs
MedTech Europe